uniQure to Host Virtual Research & Development Event on Tuesday, November 29, 2022
November 17 2022 - 7:05AM
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced that it will host a Virtual Research &
Development Event on Tuesday, November 29, 2022 from 8:30 a.m. to
10:30 a.m. EST.
The event will focus on the unmet medical need
of patients with refractory temporal lobe epilepsy (rTLE) and the
Company’s preclinical gene therapy candidate for rTLE, AMT-260,
that is anticipated to enter clinical development in 2023. Ellen
Bubrick, MD, associate chair of Neurology, Quality and Safety and
director of the Epilepsy Surgery Program at Brigham and Women’s
Hospital in Boston, Mass. and assistant professor of neurology at
Harvard Medical School, will be the featured clinical expert. Also
included in this virtual event will be presentations by uniQure’s
Research and Development team on the development of AMT-260 and a
presentation by Pierre Caloz, chief operating officer at uniQure,
outlining advancements in uniQure’s AAV manufacturing platform.
The full program will be webcast live under the
Investors section of uniQure’s website at www.uniQure.com. A replay
of the webcast will be available at uniQure’s website for 45 days
following the event.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary gene therapies to treat patients with hemophilia B,
Huntington's disease, refractory temporal lobe epilepsy, Fabry
disease, and other diseases. www.uniQure.com
uniQure Contacts: |
|
|
|
|
|
FOR INVESTORS: |
|
FOR MEDIA: |
|
|
|
Maria E. Cantor |
Chiara Russo |
Tom Malone |
Direct: 339-970-7536 |
Direct: 617-306-9137 |
Direct: 339-970-7558 |
Mobile: 617-680-9452 |
Mobile: 617-306-9137 |
Mobile: 339-223-8541 |
m.cantor@uniQure.com |
c.russo@uniQure.com |
t.malone@uniQure.com |
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024